Author: Newsdesk

Posted on

Sunshine Retirement Living Expands U.S. Footprint with Management Agreement for Five New Independent Living Communities

PR Newswire


BEND, Ore.
, Aug. 20, 2025 /PRNewswire/ — Sunshine Retirement Living, a leading provider of mid-market senior living communities in the United States, is expanding its national footprint through a new management agreement with Sabra Health Care REIT, Inc. (Nasdaq: SBRA). This agreement adds five independent living communities across four Western states, growing Sunshine Retirement Living’s portfolio from 35 to 40 communities in 17 states. The new communities are located in Arizona, California, Utah and Washington.

Marking its first third-party management agreement, Sunshine Retirement Living is expanding its proven model of high-quality, all-inclusive senior living to these new communities while staying true to its core values of affordability, compassionate care, vibrant community engagement, and culinary excellence. This milestone also represents a strategic evolution for Sunshine, transitioning from an owner-operator to a full-scale third-party management provider.

“With demand for senior housing continuing to grow, this agreement accelerates Sunshine Retirement Living’s expansion,” said Luis Serrano, CEO of Sunshine Retirement Living. “By extending our proven service model to third-party owners, we are broadening our reach and reinforcing our mission to enhance the lives of seniors nationwide.”

For over 20 years, family-owned Sunshine Retirement Living has been a trusted provider of mid-market senior living, offering senior apartments, independent living, assisted living, transitional assisted living, and memory care. The mid-market segment remains one of the most underserved yet fastest-growing areas in senior housing, and Sunshine Retirement Living continues to pioneer innovative solutions that make high-quality senior living accessible.

“With Baby Boomers retiring in record numbers and the 85+ population expected to triple by 2050, seniors are seeking dynamic, wellness-focused communities,” said Serrano. “Sunshine Retirement Living is answering that call with forward-thinking initiatives in person-centered care, culinary innovation, community-centered design, and holistic well-being.”

Unlike luxury senior living options that are financially out of reach for many, Sunshine Retirement Living is dedicated to ensuring the mid-market remains viable—balancing affordability with exceptional care. Notably, as wellness-focused living becomes increasingly important for seniors, Sunshine Retirement Living offers innovative programs that promote physical fitness, mindfulness, and lifelong learning. The company has also become culinary-forward to help people live longer, healthier and happier lives, recently introducing the Blue Zones program, inspired by principles that help people live longer, healthier and happier lives. Residents enjoy chef-inspired meals with nutritionally sound, locally sourced ingredients plus chef’s table demonstrations and cooking classes that encourage socialization.

With favorable long-term demographic trends and a growing need for quality senior housing, Sunshine Retirement Living anticipates continued expansion in the coming years. This latest agreement reflects the company’s strategic focus on both growing its owned portfolio and extending its management services to third-party owners.

“As we continue to expand, we are actively seeking new partnerships with real estate investment trusts (REITs) and other senior housing owners looking for a proven management operator,” added Serrano. “With our established track record of delivering high-quality, affordable senior living, we are well-positioned to help owners maximize occupancy, streamline operations, and enhance resident satisfaction. We welcome discussions with REITs and investors who share our vision of making high-quality senior living accessible to more seniors nationwide.”

For more information about Sunshine Retirement Living and its communities, please visit www.SunshineRet.com.

About Sunshine Retirement Living

Based in Bend, Ore., Sunshine Retirement Living manages 40 retirement communities in 17 states, offering senior apartments, independent living, assisted living, transitional assisted living, and memory care. A family-owned business with 20 years in the senior housing industry, Sunshine Retirement Living’s mission is to be the preferred senior living provider offering value, choice and independence while promoting health and social interaction that exceeds residents’ expectations and enriches the lives of both residents and staff. By providing meals, housekeeping, activities, transportation, utilities and in-house management staff, Sunshine Retirement Living continues to build an unparalleled community feeling in each property. For more information, visit
www.SunshineRet.com
 or connect socially.

Cision View original content:https://www.prnewswire.com/news-releases/sunshine-retirement-living-expands-us-footprint-with-management-agreement-for-five-new-independent-living-communities-302533752.html

SOURCE Sunshine Retirement Living

Posted on

Edible Garden Expands Pickle Party™ Distribution Across Metro New York with Associated and Trade Fair Supermarkets, Adds FoodTown in Newburgh, NY as the Summer of Pickle Party™ Continues

BELVIDERE, NJ, Aug. 20, 2025 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced the continued expansion of its Pickle Party™ line through new retail placements at Associated Supermarket in Astoria, NY, Trade Fair Supermarkets across New York City, and Foodtown in Newburgh, NY. These partnerships extend the brand’s reach into respected regional grocers known for their commitment to quality and community, while aligning with strong seasonal demand for fresh and flavorful condiments.

Pickle Party™ is the first-of-its-kind functional pickle line, created in partnership with the fabled Hermann Pickle Company. The products are raw, refrigerated, fermented, Kosher, and Non-GMO, crafted with traditional fermentation methods recognized for supporting digestive health. Featuring bold flavor profiles that range from classic dill to fiery, globally inspired varieties, Pickle Party™ products are designed to deliver gut-friendly benefits without compromising taste or clean-label integrity.

“As we continue to expand Pickle Party™, we’re proud to partner with retailers that share our passion for delivering high-quality, innovative products to consumers,” said Jim Kras, Chief Executive Officer of Edible Garden. “By adding respected banners such as Associated, Trade Fair, and Foodtown, we are strengthening our presence in the New York Metro market while introducing more shoppers to a fresh, better-for-you take on a classic category. These relationships reflect both the appeal of the Pickle Party™ brand and our broader strategy of working with trusted regional grocers to drive sustainable growth and long-term value for our stakeholders.”

This latest rollout underscores Edible Garden’s mission to disrupt the condiments category with products that combine functionality, sustainability, and exceptional taste. By focusing on partnerships with established retailers, the Company continues to advance its growth strategy while responding to evolving consumer preferences for clean-label, health-forward foods.

ABOUT EDIBLE GARDEN®

Edible Garden AG Incorporated is a leader in controlled environment agriculture (CEA), delivering locally grown, organic, better-for-you, sustainable produce and products through its Zero-Waste Inspired® next-generation farming model. Available in over 5,000 retail locations across the United States, Caribbean, and South America, Edible Garden is at the forefront of the CEA and sustainability technology movement, distinguished by its advanced safety-in-farming protocols, sustainable packaging, patented GreenThumb software, and innovative Self-Watering in-store displays. The Company operates state-of-the-art, vertically integrated greenhouses and processing facilities, including Edible Garden Heartland in Grand Rapids, Michigan; Edible Garden Prairie Hills in Webster City, Iowa; and its headquarters at Edible Garden Belvidere in New Jersey. It also partners with a network of contract growers strategically located near major U.S. markets to ensure freshness and reduce environmental impact.

Edible Garden’s proprietary GreenThumb 2.0 software—protected by U.S. Patents US 11,158,006 B1, US 11,410,249 B2, and US 11,830,088 B2—optimizes vertical and traditional greenhouse growing conditions while aiming to reduce food miles. Its patented Self-Watering display (U.S. Patent No. D1,010,365) is designed to extend plant shelf life and elevate in-store presentation. In addition to its core CEA operations, Edible Garden owns three patents in advanced aquaculture technologies: a closed-loop shrimp farming system (US 6,615,767 B1), a modular recirculating aquaculture setup with automated water treatment and feeding (US 10,163,199 B2), and a sensor-driven ammonia control method utilizing electrolytic chlorine generation (US 11,297,809 B1).

The Company has been recognized as a FoodTech 500 firm by Forward Fooding, a leading AgriFoodTech organization, and is a Giga Guru member of Walmart’s Project Gigaton sustainability initiative. Edible Garden also develops and markets a growing line of nutrition and specialty food products, including Vitamin Way® and Vitamin Whey®—plant and whey protein powders—and Kick. Sports Nutrition, a premium performance line for health-conscious athletes seeking cleaner, better-for-you options. The Company’s offerings further include fresh, sustainable condiments such as Pulp fermented gourmet and chili-based sauces, as well as Pickle Party, a collection of fermented fresh pickles and krauts.

Learn more at https://ediblegardenag.com.

For Pulp products, visit https://www.pulpflavors.com.

For Vitamin Whey® products, visit https://vitaminwhey.com.

For Kick. Sports Nutrition products, visit https://kicksportsnutrition.net/.

Watch the Company’s latest corporate video here.

Forward-Looking Statements

This press release contains forward-looking statements, including with respect to the Company’s growth strategies, ability to expand its distribution network and distribution relationships, and performance as a public company. The words “believe,” “expect,” “intend,” “look forward,” “objective,” “plan,” “seek,” “strategy,” “will,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including market and other conditions and the Company’s ability to achieve its growth objectives. The Company undertakes no obligation to update any such forward-looking statements after the date hereof to conform to actual results or changes in expectations, except as required by law.

Investor Contacts:

Crescendo Communications, LLC
212-671-1020
[email protected]



Posted on

Maris-Tech Enters into U.S. Product Supply Agreement with One Stop Systems to Expand U.S. Defense Sector Presence

Collaboration with Leading Provider of Rugged AI and Sensor Processing Platforms Strengthens Maris-Tech’s U.S. Market Reach

Rehovot, Israel, Aug. 20, 2025 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and artificial intelligence (“AI”)-based edge computing technology, today announced that it has entered into a Product Supply Agreement with U.S.-based One Stop Systems, Inc. (Nasdaq: OSS) (“OSS”), a leader in rugged enterprise class compute for AI, machine learning, autonomy, and sensor processing at the edge.

Under the agreement, OSS will promote, support and fulfill Maris-Tech’s portfolio of video and AI-based edge computing solutions to defense sector customers in the United States. OSS manufactures and sells ruggedized compute, storage, AI accelerators, and expansion systems designed for mission-critical, high-performance applications in harsh environments.

The collaboration is aligned with Maris-Tech’s growth strategy to expand its footprint in the U.S. defense market, providing OSS customers with access to cutting-edge, field-proven solutions for intelligence gathering, situational awareness, and threat detection.

“This agreement marks an important milestone in our U.S. expansion strategy,” said Israel Bar, Chief Executive Officer of Maris-Tech. “OSS is a recognized leader in rugged AI and sensor processing systems, and we are proud to collaborate with them to deliver our technology to defense customers across the U.S. We believe this collaboration is both a vote of confidence in our products and an opportunity for OSS customers to benefit from our advanced, mission-ready solutions.”

Michael Knowles, Chief Executive Officer of OSS, said: “Maris-Tech’s video and AI-based edge computing solutions are an ideal complement to our ruggedized platforms. By combining our expertise in AI-enabled solutions with Maris-Tech’s innovative video intelligence systems, we can offer U.S. defense customers an even more powerful suite of capabilities to address their evolving mission requirements.”

Maris-Tech continues its strategy of collaboration with leading regional partnerships to extend its reach in key global markets with this agreement. The Company has recently announced similar collaborations in Asia-Pacific, Europe and India, further strengthening its international sales network.

About Maris-Tech Ltd.

Maris-Tech is a global leader in video and AI-based edge computing technology, pioneering intelligent video transmission solutions that conquer complex encoding-decoding challenges. Our miniature, lightweight, and low-power products deliver high-performance capabilities, including raw data processing, seamless transfer, advanced image processing, and AI-driven analytics. Founded by Israeli technology sector veterans, Maris-Tech serves leading manufacturers worldwide in defense, aerospace, intelligence gathering, homeland security (HLS), and communication industries. We’re pushing the boundaries of video transmission and edge computing, driving innovation in mission-critical applications across commercial and defense sectors.

For more information, visit https://www.maris-tech.com/

About One Stop Systems

One Stop Systems, Inc. (Nasdaq: OSS) is a leader in AI-enabled solutions for the demanding ‘edge’. OSS designs and manufactures Enterprise Class compute and storage products that enable rugged AI, sensor fusion and autonomous capabilities without compromise. These hardware and software platforms bring the latest data center performance to harsh and challenging applications, whether they are on land, sea or in the air. OSS products include ruggedized servers, compute accelerators, flash storage arrays, and storage acceleration software. These specialized compact products are used across multiple industries and applications, including autonomous trucking and farming, as well as aircraft, drones, ships and vehicles within the defense industry. OSS solutions address the entire AI workflow, from high-speed data acquisition to deep learning, training and large-scale inference, and have delivered many industry firsts for industrial OEM and government customers. As the fastest growing segment of the multi-billion-dollar edge computing market, AI-enabled solutions require-and OSS delivers-the highest level of performance in the most challenging environments without compromise. OSS products are available directly or through global distributors.

Forward-Looking Statement Disclaimer

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may”, “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. For example, the Company is using forward-looking statements when it is discussing the parties’ responsibilities under the agreement, that collaboration is aligned with the Company’s growth strategy to expand its footprint in the U.S. defense market, its strategy of collaboration with leading regional partnerships and the benefits and advantages of the Company’s products and solutions. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: its ability to successfully market its products and services, including in the United States; the acceptance of its products and services by customers; its continued ability to pay operating costs and ability to meet demand for its products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; its ability to successfully develop new products and services; its success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; its ability to comply with applicable regulations; and the other risks and uncertainties described in the Annual Report on Form 20-F for the year ended December 31, 2024, filed with the SEC on March 28, 2025, and its other filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Relations:

Nir Bussy, CFO
Tel: +972-72-2424022
[email protected]



Posted on

AV Delivers Initial P550 Autonomous Group 2 eVTOL Unmanned Aircraft Systems to U.S. Army for LRR Program

AV Delivers Initial P550 Autonomous Group 2 eVTOL Unmanned Aircraft Systems to U.S. Army for LRR Program

ARLINGTON, Va.–(BUSINESS WIRE)–
AeroVironment, Inc. (“AV”) (NASDAQ: AVAV), a leader in intelligent, multi-domain robotic systems, today announced the successful delivery of its Group 2 P550™ small Unmanned Aircraft Systems (sUAS) to the U.S. Army as part of the Long-Range Reconnaissance (LRR) program to support training and operations for Transformation in Contact (TiC) brigades. This initial delivery includes multiple P550 systems along with new equipment training and training master trainers to ensure mission readiness and rapid integration into the US Army TiC Brigades and other designated units.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250820653667/en/

AV’s P550™, an autonomous Group 2 eVTOL UAS, redefines battlefield adaptability, setting a new standard for rapid deployment in any environment [Credit: AV]

AV’s P550™, an autonomous Group 2 eVTOL UAS, redefines battlefield adaptability, setting a new standard for rapid deployment in any environment [Credit: AV]

This milestone marks a significant achievement for both the Army and the all-new P550 product line. Built from the ground up with a Modular Open Systems Approach (MOSA), the P550 is designed to meet evolving warfighter requirements, enabling rapid adaptation in dynamic, contested environments with multiple payload, radio, and power options to counter emerging threats and enhance lethality. It builds on decades of AV’s UAS development and production of combat-proven systems delivered to the Department of Defense and over 50 partner nations.

“We are proud to deliver the P550 to Army units, empowering warfighters with a system that can quickly adapt to fluid combat scenarios, providing unmatched reliability and flexibility,” said Trace Stevenson, AV’s President of Autonomous Systems. “Our team remains committed to supporting the Army with seamless delivery, training, and sustainment to ensure these systems are ready when needed.”

The P550 is AV’s latest autonomous Group 2 eVTOL system, redefining battlefield adaptability with rapid deployment, advanced situational awareness, and targeting and strike capabilities. Its proven AI and autonomy enable smarter, safer operations for maneuver forces. With class-leading payload capacity up to 15 pounds, endurance of up to 5 hours on all-battery power, and a Gross Take-Off Weight (GTOW) of 55 pounds, it can be reconfigured in under five minutes without tools, including hot-swapping payloads and batteries. Its open and scalable architecture not only future proofs the P550 for continuous upgrades but also keeps pace with technological advancements at low cost and risk.

The initial deliveries included comprehensive new equipment training conducted by AV’s field service representatives to ensure operators and maintainers can effectively integrate the P550 into their units. The systems were received by PM and evaluated by Master Trainers, who completed “train-the-trainer” instruction to enable rapid fielding and operational integration.

AV will continue to fulfill additional orders to support the Army’s evolving operational requirements.

About AV

AV (NASDAQ: AVAV) is a defense technology leader delivering integrated capabilities across air, land, sea, space, and cyber. The Company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities—built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. For more information, visit www.avinc.com.

Safe Harbor Statement

Certain statements in this press release may constitute “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are made on the basis of current expectations, forecasts and assumptions that involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and technological factors outside of our control, that may cause our business, strategy or actual results to differ materially from those expressed or implied. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, our ability to perform under existing contracts and obtain additional contracts; changes in the regulatory environment; the activities of competitors; failure of the markets in which we operate to grow; failure to expand into new markets; failure to develop new products or integrate new technology with current products; and general economic and business conditions in the United States and elsewhere in the world. For a further list and description of such risks and uncertainties, see the reports we file with the Securities and Exchange Commission. We do not intend, and undertake no obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Media Contact:

Ashley Young

[email protected]

703.718.4060

KEYWORDS: United States North America Virginia

INDUSTRY KEYWORDS: Aerospace Technology Manufacturing White House/Federal Government Air Robotics Transport Defense Contracts Public Policy/Government Engineering

MEDIA:

Photo
Photo
AV’s P550™, an autonomous Group 2 eVTOL UAS, redefines battlefield adaptability, setting a new standard for rapid deployment in any environment [Credit: AV]
Logo
Logo
Posted on

VCIG Launches VCI Energy, Appoints Former Franklin Templeton MD Victor Lee as CEO to Drive Clean Energy Expansion

Move Marks VCIG’s formal entry into the US$1.5 Trillion Clean Energy Transition Market, Aligning Sustainability with Shareholder Value Creation

KUALA LUMPUR, Malaysia, Aug. 20, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), a cross-sector platform builder integrating deep technology with financial architecture to enable sovereign-ready digital ecosystems, today announced the launch of VCI Energy Limited (“VCI Energy”), a wholly owned subsidiary dedicated to clean energy and sovereign-scale infrastructure. This move represents VCI Global’s formal entry into the global clean energy infrastructure sector.

To drive this initiative, VCI Global has appointed Victor Lee, former Managing Director of Franklin Templeton, as Chief Executive Officer of VCI Energy. Mr. Lee brings extensive experience in institutional investment and infrastructure financing, positioning the subsidiary to capture capital-efficient, large-scale opportunities across renewable generation, energy storage, and sovereign energy infrastructure.

“Energy is the backbone of sovereignty, and one of the most attractive long-term investment opportunities. By establishing VCI Energy, VCI Global is extending its cross-sector platform into a market with exceptional growth visibility and global demand. Under Victor Lee’s leadership, we expect VCI Energy to unlock scalable partnerships, recurring revenue streams, and long-term value creation for our shareholders,” said Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global.

VCI Energy’s initial focus will be on three high-growth verticals:

  • Clean Energy Generation & Storage: investments in renewable energy assets and next-generation battery and microgrid systems to strengthen energy independence.
  • Sovereign Energy Infrastructure: integrated frameworks designed to align with national strategies for digital, AI, and data sovereignty.
  • Strategic Partnership & Investments: collaboration with governments, utilities, and institutional investors to deliver large-format clean energy projects across Asia and beyond.

The clean energy infrastructure market is entering a rapid expansion phase, fuelled by rising global energy demand, government decarbonization targets, and the integration of digital and AI-driven infrastructure. According to Allied Market Research, the sector is forecasted to grow at a 9.3% compound annual growth rate, reaching approximately US$1.5 trillion by 2033. Asia Pacific is expected to represent one of the fastest-growing regions, driven by large-scale renewable deployment, electrification initiatives, and sovereign investment in energy resilience, an area where VCI Energy is uniquely positioned to compete.

“I am honoured to lead VCI Energy at such a pivotal moment in the global energy transition. Our vision is to create a clean energy platform that combines sustainability with sovereignty and delivers strong returns for investors while contributing to the world’s shift toward resilient and future-ready energy systems,” said Victor Lee, CEO of VCI Energy.

About VCI Energy Limited

VCI Energy, a wholly owned subsidiary of VCI Global Limited (NASDAQ: VCIG), is dedicated to advancing clean energy generation, storage, and sovereign-scale infrastructure. The company partners with governments, utilities, and institutional investors to deliver renewable and energy resilience projects that combine sustainability with sovereignty. Leveraging VCIG’s cross-sector expertise in AI, cybersecurity, and capital markets, VCI Energy is positioned to play a pivotal role in the global transition toward clean and resilient energy systems.

About VCI Global Limited

VCI Global is a cross-sector platform builder integrating deep technology with financial architecture to enable sovereign-ready digital ecosystems. Evolving from its roots in capital markets consultancy, the company now operates across fintech, AI, robotics, and cybersecurity.

Its mission is to empower governments, enterprises, and institutions, particularly in Southeast Asia, to scale securely, intelligently, and independently. At the core of its latest innovations is a sovereign AI data platform fortified by proprietary military-grade encryption, built to meet the highest standards of digital sovereignty, national security, and enterprise resilience.

For more information on the Company, please log on to https://v-capital.co/. 

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. These forward-looking statements are based only on our current beliefs, expectations, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Therefore, you should not rely on any of these forward-looking statements. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including without limitation, the Company’s ability to achieve profitable operations, customer acceptance of new products, the effects of the spread of coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company’s products and the Company’s customers’ economic condition, the impact of competitive products and pricing, successfully managing and, general economic conditions and other risk factors detailed in the Company’s filings with the United States Securities and Exchange Commission (“SEC”). The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update the forward-looking statements in this release, except in accordance with applicable law.

CONTACT INFORMATION:

For media queries, please contact:

VCI GLOBAL LIMITED
[email protected]



Posted on

American Express Adds to its Expansive Global Sports and Entertainment Portfolio with New Partnerships with Hard Rock Stadium, the Formula 1® Crypto.com Miami Grand Prix and the Miami Dolphins

American Express Adds to its Expansive Global Sports and Entertainment Portfolio with New Partnerships with Hard Rock Stadium, the Formula 1® Crypto.com Miami Grand Prix and the Miami Dolphins

Amex Presale Tickets™ for the Formula 1® Crypto.com Miami Grand Prix Will Be On-Sale August 20 Through August 25, exclusively for Card Members

NEW YORK–(BUSINESS WIRE)–
American Express will now offer even more access and perks for Card Members in South Florida as the new Official Payments Partner of Hard Rock Stadium, the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX and the Miami Dolphins. The new, multi-year partnership will provide eligible Amex® Card Members with access to Amex Presale Tickets™, special fan experiences, exclusive lounges and more.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250819192568/en/

Photo credit: FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX

Photo credit: FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX

“As Amex continues to grow its powerhouse portfolio of sports and entertainment sponsorships globally, these new partnerships in Miami elevate the access and experience for our Card Members and enhance the value of their Membership,” said Bess Spaeth, Executive Vice President, Global Brand Management and Experiences, American Express. “We’re committed to showing up for our Card Members at the moments they love the most, and offering unique ways to make them even more special.”

“We are excited to partner with American Express to bring even more value to fans across our events at Hard Rock Stadium, including Miami Dolphins games and the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX,” said Jason Green, Senior Vice President and Chief Revenue Officer for Hard Rock Stadium, the Miami Dolphins and the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX. “This partnership is rooted in our shared commitment to enhance the customer experience and we are thrilled to work with Amex to bring a host of new benefits for our guests and their Card Members to enjoy here in Miami Gardens.”

Amex’s sponsorship of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX follows its 2025 expansion into more than 20 races around the world. At the 2026 FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX – scheduled for May 1-3, 2026 – Amex will create an immersive Fan Experience, provide perks for Card Members like the beloved Amex Race Radios to listen to all of the track action, and more. Beginning today, August 20th, at 12pm ET through August 25th at 12pm, Card Members have access to Amex Presale Tickets™ for Grandstand seats while supplies last. Tickets and perks available while supplies last. Terms apply. Learn more here.

As part of this new deal, Hard Rock Stadium will join the American Express Venue Collection™, a benefit for eligible Card Members which includes an assortment of perks at arenas and entertainment venues around the globe, beginning with 2025 Miami Dolphins regular season games and entertainment events at Hard Rock Stadium. As a part of the American Express Venue Collection™, eligible Card Members can enroll to access an exclusive concession offer, plus all Card Members have access to Amex Presale Tickets™ and a dedicated Card Member entrance. Platinum Card® Members will also have access to an exclusive lounge in Hard Rock Stadium located on the Empower Club and Suite Level in the West Endzone. Tickets available while supplies last. Capacity limitations and terms apply.

These new sponsorships enhance American Express’ world-class portfolio of sports and entertainment partnerships around the globe, across basketball, tennis, golf, music, theater, and more.

ABOUT AMERICAN EXPRESS

American Express (NYSE: AXP) is a global payments and premium lifestyle brand powered by technology. Our colleagues around the world back our customers with differentiated products, services and experiences that enrich lives and build business success.

Founded in 1850 and headquartered in New York, American Express’ brand is built on trust, security, and service, and a rich history of delivering innovation and Membership value for our customers. With over a hundred million merchant locations across our global network, we seek to provide the world’s best customer experience every day to a broad range of consumers, small and medium-sized businesses, and large corporations.

For more information about American Express, visit americanexpress.com, americanexpress.com/en-us/newsroom/, and ir.americanexpress.com.

ABOUT HARD ROCK STADIUM

Hard Rock Stadium is a global entertainment destination and curator of world-class events. The best-in-class venue is home to the Miami Dolphins, University of Miami Hurricanes football team, the Orange Bowl, Formula 1® Crypto.com Miami Grand Prix, Miami Open presented by Itaú, major concerts, the 2026 College Football Playoff National Championship Game and FIFA World Cup 2026™. Due to its overall sustainability efforts, the multifunctional venue holds Leadership in Energy and Environmental Design (LEED) Gold certification and FIA Three-Star Environmental Accreditation rating. For more information, visit hardrockstadium.com.

Media Contacts:

American Express

Curt Villarosa

[email protected]

Hard Rock Stadium / Miami Dolphins / F1 Miami Grand Prix

Brett Brecheisen

[email protected]

KEYWORDS: United States North America Florida New York

INDUSTRY KEYWORDS: Entertainment Sports Football General Entertainment Events/Concerts Motor Sports General Sports

MEDIA:

Photo
Photo
Photo credit: FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX
Logo
Logo
Posted on

Rackspace Unveils ‘RAISE’: An AI-Driven Security Engine that Adapts in Real Time to Cyber Threats

AI enhancements provide 24/7 threat detection and response, unifying data across complex tech ecosystems for swift, informed action

SAN ANTONIO, Aug. 20, 2025 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading hybrid cloud and AI solutions provider, today announced key AI-enabled enhancements to the Rackspace Cyber Defense Center (RCDC), a dedicated security operations center (SOC), to deliver around-the-clock threat detection, isolation, and remediation across public, private and hybrid cloud environments.

Driving innovation within the RCDC is the Rackspace AI Security Engine (RAISE), which bridges critical skills and resource gaps by combining human expertise with machine-driven precision. RAISE performs signal processing, detects patterns often missed by traditional controls, and recommends remediation actions using real-time trend analysis. Events are enriched with context including probable cause, attack paths, and suggested triage which allows Rackspace’s SOC engineers to act quickly and decisively.

With each incident, RAISE learns and evolves, enabling a closed-loop model of adaptive intelligence that continuously improves detection, response and communication. This self-improving model reinforces effective strategies and refines future actions, enabling faster, smarter, and more resilient cybersecurity operations over time.

“Our delivery model blends human expertise with advanced AI and automation, enabling faster, more consistent, and more confident decisions. These enhancements provide a seamless, end-to-end experience, from threat detection to resolution, which is not only efficient but also easy for stakeholders across the business to understand and act on,” said D K Sinha, President, Public Cloud at Rackspace Technology. “The RCDC combines Rackspace’s decades of operational expertise with deep telemetry insights and proprietary technology to deliver continuous, real-time protection that adapts to today’s evolving threat landscape.”

The advanced capabilities of RAISE propelled Rackspace to be recognized as a leader in cybersecurity by the Information Services Group (ISG). In its 2025 Provider Lens™ Cybersecurity – Services & Solutions Report, which highlights organizations with proven expertise in delivering advanced, end-to-end cybersecurity solutions, ISG named Rackspace a leader in three key categories: Strategic Security Services, Next-Gen SOC MDR Services, and Technical Security Services.

ISG noted the advancements of RAISE in their report and stated, “Rackspace Technology integrates AI across its SOC operations through Rackspace AI Security Engine (RAISE), accelerating threat detection and response while minimizing manual overhead. This automation enhances incident triage, reduces response times and ensures that critical security events are addressed with precision. RAISE empowers SOC analysts with contextual insights, supporting swift decision-making and improved workflows.”  

Learn more about increasing cyber resilience with the Rackspace Cyber Defense Center: Cyber Defense With Adaptive Intelligence | Rackspace Technology

About Rackspace Technology

Rackspace Technology is a leading end-to-end, hybrid and AI solutions company. We can design, build, and operate our customers’ cloud environments across all major technology platforms, irrespective of technology stack or deployment model. We partner with our customers at every stage of their cloud journey, enabling them to modernize applications, build new products, and adopt innovative technologies.

Media Contact:
Cheryl Amerine
[email protected]



Posted on

Morgan Stanley Investment Management’s 1GT Invests in Series C Funding for Overhaul Group

Morgan Stanley Investment Management’s 1GT Invests in Series C Funding for Overhaul Group

NEW YORK–(BUSINESS WIRE)–
Morgan Stanley Investment Management (MSIM) announced today that the 1GT climate private equity strategy (1GT) participated in the $105 million Series C equity financing of Overhaul Group (Overhaul or the Company), a global leader of in-transit cargo risk management solutions. The Series C funding round was led by Springcoast Partners with participation from existing investor Edison Partners. This growth investment will support Overhaul’s continued technological advancement and strategic acquisition roadmap to establish a leading real-time supply chain risk management and intelligence platform.

Overhaul was founded in 2016 with the vision of providing a single, unified platform for in-transit supply chain management, operating around the world. The Company’s proprietary IoT-enabled software provides real-time cargo tracking and protection, while proactively responding to threats to asset integrity.

“We appreciate our partnership with Springcoast and Edison and are thrilled to welcome Morgan Stanley to the Overhaul journey,” said Barry Conlon, CEO of Overhaul. “Their backing not only validates our mission to build the world’s most secure and intelligent supply chain platform but also equips us with the resources to accelerate innovation, expand our global reach, and continue delivering unmatched value to our customers. With this new partnership, we’re advancing our commitment to sustainability, resilience, and operational excellence at a critical moment in global logistics.”

“Overhaul operates at the intersection of two large and growing markets of supply chain visibility software and cargo risk management, providing critical solutions to customers navigating increasing supply chain complexity and disruptions,” said Jake Van Koevering, Partner in MSIM’s 1GT. “Overhaul’s proprietary software solution enables customers to increase the security and efficiency of their supply chain operations, while reducing their emissions by unlocking lower carbon transportation modes for high-value products.”

“We are very much looking forward to bringing the full scope of Morgan Stanley’s global platform to support Overhaul’s compelling sustainability proposition as Barry and the team move forward into the next phase of the company’s growth,” added Vikram Raju, MSIM’s Head of Climate Private Equity Investing.

Overhaul safeguards over $1.4 trillion in cargo trade continuously, achieving a 99.9% shipment protection rate. The Company aims to remain at the forefront of enabling businesses to build world-class, secure, and resilient operations, especially during unprecedented global supply chain changes.

About Overhaul Group, Inc.

Founded in 2016 with offices around the world, Overhaul is the global leader in active supply chain risk management and intelligence. Overhaul protects shippers and 3PLs from in-transit cargo delays, damage, theft, and spoilage through advanced software and monitoring solutions. With 7 global monitoring control towers strategically located worldwide, Overhaul offers continuous cargo protection and immediate, proactive responses to threats. Overhaul maintains a strong, direct partnership with law enforcement agencies, ensuring rapid recovery and intervention in the event of theft. Trusted by leading enterprises, Overhaul serves industries including pharmaceuticals, healthcare, technology, logistics, retail, and food and beverage, with clients such as Microsoft, Bristol Myers Squibb, Dyson, and CEVA Logistics. For more information, visit over-haul.com, and follow them on LinkedIn, X, and Facebook.

About Springcoast Partners

Established in 2023, Springcoast is a New York-based growth equity firm focused on partnering with market leading software and technology companies. To learn more about Springcoast, please visit www.springcoast.com

About Morgan Stanley Climate Private Equity

Morgan Stanley Climate Private Equity manages 1GT, a strategy that invests in growth companies delivering innovative climate solutions that meaningfully decarbonize the global economy. The strategy is focused on scaling opportunities in the Power, Mobility, Food & Agriculture, and Circularity themes across North America and Europe, with an emphasis on driving significant organic growth by leveraging the global breadth of Morgan Stanley capabilities. For further information, please visit https://www.morganstanley.com/im/1gt.

About Morgan Stanley Investment Management

Morgan Stanley Investment Management, together with its investment advisory affiliates, has more than 1,300 investment professionals around the world and $1.7 trillion in assets under management or supervision as of June 30, 2025. Morgan Stanley Investment Management strives to provide strong long-term investment performance, outstanding service, and a comprehensive suite of investment management solutions to a diverse client base, which includes governments, institutions, corporations and individuals worldwide. For further information about Morgan Stanley Investment Management, please visit https://www.morganstanley.com/im

About Morgan Stanley

Morgan Stanley (NYSE: MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the Firms employees serve clients worldwide including corporations, governments, institutions and individuals. For further information about Morgan Stanley, please visit https://www.morganstanley.com/

Press

Morgan Stanley: Alyson Barnes

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Socially Responsible Investing Technology Professional Services Transport Asset Management Software Other Professional Services Logistics/Supply Chain Management Environment Finance Sustainability

MEDIA:

Posted on

Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

Approval Facilitates Immediate Offshored and Outsourced Manufacturing

Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability

Transition to Outsourced Production Reduces Fixed Costs and Supports Trinity’s Broader Profitability and Growth Objectives

DUBLIN, Aug. 20, 2025 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that the in-country healthcare product regulatory authority has granted the key approval to initiate offshore and outsourced manufacturing of its flagship World Health Organization (WHO) prequalified TrinScreen™ HIV rapid test.

This key approval now enables Trinity Biotech to transition upstream production from its legacy in-house operations to a more cost-effective and scalable outsourced model, while maintaining the highest levels of product integrity and regulatory compliance. Trinity Biotech has now begun manufacturing under this new model, marking a critical milestone in the Company’s transformation strategy.  The strategic shift is expected to:

  • Expand gross margins.
  • Free up working capital.
  • Reduce fixed costs, supporting broader profitability and growth objectives.

This latest approval builds on the previously announced WHO approval for the offshored and outsourced upstream manufacturing activities of Trinity Biotech’s high-volume TrinScreen™ HIV rapid test.

“This key regulatory approval is a major step forward in our transformation journey,” said John Gillard, President and Chief Executive Officer of Trinity Biotech. “It builds on our earlier WHO authorization and allows us to fully operationalize our offshore manufacturing model for TrinScreen™ HIV. This transition unlocks significant cost efficiencies, enhances scalability, and positions the Company for long-term financial health.”

Forward-Looking Statements

This release includes statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”), including but not limited to statements related to Trinity Biotech’s cash position, financial resources and potential for future growth, market acceptance and penetration of new or planned product offerings, and future recurring revenues and results of operations. Trinity Biotech claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms “may,” “believes,” “projects,” “expects,” “anticipates,” or words of similar import, and do not reflect historical facts. Specific forward-looking statements contained in this release may be affected by risks and uncertainties, including, but not limited to, our ability to capitalize on the Waveform transaction and of our recent acquisitions, our continued listing on the Nasdaq Stock Market, our ability to achieve profitable operations in the future, the impact of the spread of COVID-19 and its variants, the possible pause and/or disruption in U.S. Government funding for HIV tests produced by Trinity Biotech, potential excess inventory levels and inventory imbalances at the company’s distributors, losses or system failures with respect to Trinity Biotech’s facilities or manufacturing operations, the effect of exchange rate fluctuations on international operations, fluctuations in quarterly operating results, dependence on suppliers, the market acceptance of Trinity Biotech’s products and services, the continuing development of its products, required government approvals, risks associated with manufacturing and distributing its products on a commercial scale free of defects, risks related to the introduction of new instruments manufactured by third parties, risks associated with competing in the human diagnostic market, risks related to the protection of Trinity Biotech’s intellectual property or claims of infringement of intellectual property asserted by third parties and risks related to condition of the United States economy and other risks detailed under “Risk Factors” in Trinity Biotech’s annual report on Form 20-F for the fiscal year ended December 31, 2024 and Trinity Biotech’s other periodic reports filed from time to time with the United States Securities and Exchange Commission. Forward-looking statements speak only as of the date the statements were made. Trinity Biotech does not undertake and specifically disclaims any obligation to update any forward-looking statements.

About Trinity Biotech


Trinity Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has recently entered the wearable biosensor industry, with the acquisition of the biosensor assets of Waveform Technologies Inc. and intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Our products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information, please see the Company’s website: www.trinitybiotech.com.

Contact: Trinity Biotech plc

Susan O’Connor
(353)-1-2769800 		RedChip Companies Inc.

Dave Gentry, CEO
(1)-407-644-4256
(1)-800-RED-CHIP (733-2447)
[email protected]



Posted on

RedHill Biopharma Awarded $1.8 Million in Legal Costs and Expenses by New York Supreme Court in Addition to its Prior $8.25 Million Summary Judgment Win

PR Newswire

The New York Supreme Court has awarded RedHill approximately $1.82 million in legal costs and expenses following, and in addition to, the Court’s prior summary judgment of approximately $8.25 million in favor of RedHill in its action against Kukbo Co. Ltd’s (“Kukbo”); the $8.25 million and $1.82 million awards include 9% ongoing statutory interest accrual

RALEIGH, N.C. and TEL-AVIV, Israel, Aug. 20, 2025 /PRNewswire/ — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that the New York Supreme Court has awarded RedHill approximately $1.82 million in legal costs and expenses (including interest) in its action against Kukbo. The award follows, and is in addition to, the New York Supreme Court’s prior summary judgement award of approximately $8.25 million (including interest) in favor of RedHill.

RedHill Biopharma Logo

 

9% ongoing statutory interest accrual is applicable to both the original summary judgment and the award of legal costs and expenses.

RedHill also succeeded in its application to Korea’s Incheon District Court for an attachment grant against Kukbo. This provides a court-ordered seizure (attachment) of Kukbo’s assets, preventing their disposal prior to judgment enforcement.

Kukbo appealed the summary judgment decision on December 4, 2024, and the parties have since completed briefing on that appeal with oral argument tentatively scheduled for the September term.  Kukbo also has a right to seek an appeal of the award of legal costs and expenses.

About RedHill Biopharma
RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on U.S. development and commercialization of drugs for gastrointestinal diseases, infectious diseases and oncology. RedHill promotes the FDA approved gastrointestinal drug Talicia®, for the treatment of Helicobacter pylori (H. pylori) infection in adults[1]. RedHill’s key clinical late-stage development programs include: (i) opaganib (ABC294640), a first-in-class, orally administered sphingosine kinase-2 (SPHK2) selective inhibitor with anti-inflammatory, antiviral, and anticancer activity, targeting multiple indications with U.S. government and academic collaborations for development for radiation and chemical exposure indications such as GI-Acute Radiation Syndrome (GI-ARS), a Phase 2/3 program for hospitalized COVID-19, and a Phase 2 study in prostate cancer in combination with darolutamide; (ii) RHB-204, a next-generation optimized formulation of RHB-104, with a planned Phase 2 study for Crohn’s disease (based on RHB-104’s positive Phase 3 Crohn’s disease study results) and Phase 3-stage for pulmonary nontuberculous mycobacteria (NTM) disease; (iii) RHB-107 (upamostat), an oral broad-acting, host-directed, serine protease inhibitor with potential for pandemic preparedness, is in late-stage development as a treatment for non-hospitalized symptomatic COVID-19 and is also targeting multiple other cancer and inflammatory gastrointestinal diseases; and (iv) RHB-102, with potential UK submission for chemotherapy and radiotherapy induced nausea and vomiting, positive results from a U.S. Phase 3 study for acute gastroenteritis and gastritis and positive results from a U.S. Phase 2 study for IBS-D. RHB-102 is partnered with Hyloris Pharma (EBR: HYL) for worldwide development and commercialization outside North America.

More information about the Company is available at www.redhillbio.com / X.com/RedHillBio.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and may discuss investment opportunities, stock analysis, financial performance, investor relations, and market trends. Such statements, including, but not limited to, statements regarding the intended use of net proceeds from the offering, may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words and include statements regarding the risk that the Company will not comply with the listing requirements of the Nasdaq Capital Market (“Nasdaq”) to remain listed for trading on Nasdaq, the addition of new revenue generating products, out-licensing of the Company’s development pipeline assets, timing of opaganib’s development for Acute Radiation Syndrome, non-dilutive development funding from RHB-107 and its inclusion in a key platform study. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified, and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, market and other conditions, the risk that the addition of new revenue generating products or out-licensing transactions will not occur; the risk that the Kukbo appeal is successful; the risk that acceptance onto the RNCP Product Development Pipeline will not guarantee ongoing development or that any such development will not be completed or successful; the risk that the FDA does not agree with the Company’s proposed development plans for opaganib for any indication, the risk that observations from preclinical studies are not indicative or predictive of results in clinical trials; the risk that the FDA pre-study requirements will not be met and/or that the Phase 3 study of RHB-107 in COVID-19 outpatients will not be approved to commence or if approved, will not be completed or, should that be the case, that we will not be successful in obtaining alternative non-dilutive development funding for RHB-107, the risk that HB-107’s late-stage development for non-hospitalized COVID-19 will not benefit from the resources redirected from the terminated RHB-204 Phase 3 study, that the Phase 2/3 COVID-19 study for RHB-107 may not be successful and, even if successful, such studies and results may not be sufficient for regulatory applications, including emergency use or marketing applications, and that additional COVID-19 studies for opaganib and RHB-107 are likely to be required, as well as risks and uncertainties associated with the risk that the Company will not successfully commercialize its products; as well as risks and uncertainties associated with (i) the initiation, timing, progress and results of the Company’s research, manufacturing, pre-clinical studies, clinical trials, and other therapeutic candidate development efforts, and the timing of the commercial launch of its commercial products and ones it may acquire or develop in the future; (ii) the Company’s ability to advance its therapeutic candidates into clinical trials or to successfully complete its pre-clinical studies or clinical trials or the development of a commercial companion diagnostic for the detection of MAP; (iii) the extent and number and type of additional studies that the Company may be required to conduct and the Company’s receipt of regulatory approvals for its therapeutic candidates, and the timing of other regulatory filings, approvals and feedback; (iv) the manufacturing, clinical development, commercialization, and market acceptance of the Company’s therapeutic candidates and Talicia®; (v) the Company’s ability to successfully commercialize and promote Talicia® and Aemcolo®; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) the Company’s ability to acquire products approved for marketing in the U.S. that achieve commercial success and build its own marketing and commercialization capabilities; (viii) the interpretation of the properties and characteristics of the Company’s therapeutic candidates and the results obtained with its therapeutic candidates in research, pre-clinical studies or clinical trials; (ix) the implementation of the Company’s business model, strategic plans for its business and therapeutic candidates; (x) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its therapeutic candidates and its ability to operate its business without infringing the intellectual property rights of others; (xi) parties from whom the Company licenses its intellectual property defaulting in their obligations to the Company; (xii) estimates of the Company’s expenses, future revenues, capital requirements and needs for additional financing; (xiii) the effect of patients suffering adverse experiences using investigative drugs under the Company’s Expanded Access Program; (xiv) competition from other companies and technologies within the Company’s industry; and (xv) the hiring and employment commencement date of executive managers. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 20-F filed with the SEC on April 10, 2025. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement, whether as a result of new information, future events or otherwise unless required by law.


Company contact:



Adi Frish


Chief Corporate & Business Development Officer

RedHill Biopharma

+972-54-6543-112


[email protected]

Category: Corporate

1Talicia® (omeprazole magnesium, amoxicillin and rifabutin) is indicated for the treatment of H. pylori infection in adults. For full prescribing information see: www.Talicia.com.

Logo: https://mma.prnewswire.com/media/1334141/5268648/RedHill_Biopharma_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/redhill-biopharma-awarded-1-8-million-in-legal-costs-and-expenses-by-new-york-supreme-court-in-addition-to-its-prior-8-25-million-summary-judgment-win-302534579.html

SOURCE RedHill Biopharma Ltd.